DK445884A - Fremgangsmaade til fremstilling af 1,4-dialkyl-3-methyl-4-(3-substitueret phenyl)-piperidiner og mellemprodukt til brug ved fremgangsmaaden - Google Patents

Fremgangsmaade til fremstilling af 1,4-dialkyl-3-methyl-4-(3-substitueret phenyl)-piperidiner og mellemprodukt til brug ved fremgangsmaaden Download PDF

Info

Publication number
DK445884A
DK445884A DK445884A DK445884A DK445884A DK 445884 A DK445884 A DK 445884A DK 445884 A DK445884 A DK 445884A DK 445884 A DK445884 A DK 445884A DK 445884 A DK445884 A DK 445884A
Authority
DK
Denmark
Prior art keywords
piperidines
dialkyl
intermediates
methyl
preparing
Prior art date
Application number
DK445884A
Other languages
Danish (da)
English (en)
Other versions
DK445884D0 (da
Inventor
Charles Jackson Barnett
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK445884D0 publication Critical patent/DK445884D0/da
Publication of DK445884A publication Critical patent/DK445884A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • C07D211/52Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK445884A 1983-09-21 1984-09-19 Fremgangsmaade til fremstilling af 1,4-dialkyl-3-methyl-4-(3-substitueret phenyl)-piperidiner og mellemprodukt til brug ved fremgangsmaaden DK445884A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/534,468 US4581456A (en) 1983-09-21 1983-09-21 Processes for preparing picenadol precursors and novel intermediates thereof

Publications (2)

Publication Number Publication Date
DK445884D0 DK445884D0 (da) 1984-09-19
DK445884A true DK445884A (da) 1985-03-22

Family

ID=24130174

Family Applications (1)

Application Number Title Priority Date Filing Date
DK445884A DK445884A (da) 1983-09-21 1984-09-19 Fremgangsmaade til fremstilling af 1,4-dialkyl-3-methyl-4-(3-substitueret phenyl)-piperidiner og mellemprodukt til brug ved fremgangsmaaden

Country Status (11)

Country Link
US (1) US4581456A (ko)
EP (2) EP0136863B1 (ko)
JP (1) JPS6094961A (ko)
KR (1) KR870000270B1 (ko)
CA (1) CA1223258A (ko)
DE (1) DE3471301D1 (ko)
DK (1) DK445884A (ko)
GB (1) GB2146641B (ko)
GR (1) GR80426B (ko)
HU (1) HUT35247A (ko)
IL (1) IL72998A (ko)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5319087A (en) * 1987-04-16 1994-06-07 Eli Lilly And Company Piperidine opioid antagonists
US4992450A (en) * 1987-04-16 1991-02-12 Eli Lilly And Company Piperidine opioid antagonists
US4891379A (en) * 1987-04-16 1990-01-02 Kabushiki Kaisha Kobe Seikosho Piperidine opioid antagonists
US5136040A (en) * 1991-02-26 1992-08-04 Eli Lilly And Company Preparation of substituted tetrahydropyridines
US5159081A (en) * 1991-03-29 1992-10-27 Eli Lilly And Company Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
US5250542A (en) * 1991-03-29 1993-10-05 Eli Lilly And Company Peripherally selective piperidine carboxylate opioid antagonists
US5270328A (en) * 1991-03-29 1993-12-14 Eli Lilly And Company Peripherally selective piperidine opioid antagonists
WO2000012476A1 (en) * 1998-08-28 2000-03-09 Reilly Industries, Inc. Processes for preparing 2-piperidineethanol compounds
GB9912415D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912417D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912413D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912411D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912416D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
GB9912410D0 (en) 1999-05-28 1999-07-28 Pfizer Ltd Compounds useful in therapy
US6451806B2 (en) 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
US20050148630A1 (en) * 2003-12-02 2005-07-07 Carpenter Randall L. Methods of preventing and treating non-opioid induced gastrointestinal dysfunction
US8946262B2 (en) * 2003-12-04 2015-02-03 Adolor Corporation Methods of preventing and treating gastrointestinal dysfunction
US20050240177A1 (en) * 2004-04-26 2005-10-27 Packaging Service Corporation Of Kentucky Electrosurgical forceps
US7700626B2 (en) * 2004-06-04 2010-04-20 Adolor Corporation Compositions containing opioid antagonists
US20060211733A1 (en) * 2005-03-04 2006-09-21 Adolor Corporation Methods of preventing and treating opioid bowel dysfunction
US8524731B2 (en) * 2005-03-07 2013-09-03 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9662325B2 (en) 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US9662390B2 (en) * 2005-03-07 2017-05-30 The University Of Chicago Use of opioid antagonists to attenuate endothelial cell proliferation and migration
US8518962B2 (en) 2005-03-07 2013-08-27 The University Of Chicago Use of opioid antagonists
US7914776B2 (en) * 2005-10-07 2011-03-29 Adolor Corporation Solid dispersions of opioid antagonists
US20070092576A1 (en) * 2005-10-20 2007-04-26 Adolor Corporation Compositions containing opioid antagonists
EP2278966B1 (en) 2008-03-21 2019-10-09 The University of Chicago Treatment with opioid antagonists and mtor inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2892842A (en) * 1959-06-30 Their preparation
US2845431A (en) * 1952-04-22 1958-07-29 Hoffmann La Roche Alkyl-piperidiones and process for the manufacture thereof
US3177258A (en) * 1960-02-24 1965-04-06 Engelhard Ind Inc Hydrogenation process using rutheniumcontaining catalysts
US3946086A (en) * 1970-10-28 1976-03-23 Felix Borisovich Gershanov Method of producing 2,6-dialkyl- and 2,6-diaralkyl-substituted derivatives of p-cresol
AR206937A1 (es) * 1974-09-06 1976-08-31 Lilly Co Eli Procedimiento para preparar compuestos de 1-sustituido-4-alquil-4-fenil-piperidina
US4115400A (en) * 1976-05-27 1978-09-19 Eli Lilly And Company 1-Azoniabicyclo[3.1.0]hexanes
US4284635A (en) * 1978-11-29 1981-08-18 Eli Lilly And Company Analgesic 1,2,4,5-tetra-alkyl-4-arylpiperidines
US4228288A (en) * 1978-11-29 1980-10-14 Eli Lilly And Company Certain substituted 3,4,5,6-tetrahydropyridinium salt intermediates

Also Published As

Publication number Publication date
KR850002469A (ko) 1985-05-13
GB2146641A (en) 1985-04-24
CA1223258A (en) 1987-06-23
GB8423601D0 (en) 1984-10-24
JPS6094961A (ja) 1985-05-28
GB2146641B (en) 1987-05-28
EP0247639A2 (en) 1987-12-02
HUT35247A (en) 1985-06-28
KR870000270B1 (ko) 1987-02-23
DK445884D0 (da) 1984-09-19
IL72998A (en) 1988-03-31
US4581456A (en) 1986-04-08
GR80426B (en) 1985-01-22
EP0247639A3 (en) 1988-07-06
EP0136863A2 (en) 1985-04-10
DE3471301D1 (en) 1988-06-23
EP0136863A3 (en) 1985-07-31
EP0136863B1 (en) 1988-05-18

Similar Documents

Publication Publication Date Title
DK445884A (da) Fremgangsmaade til fremstilling af 1,4-dialkyl-3-methyl-4-(3-substitueret phenyl)-piperidiner og mellemprodukt til brug ved fremgangsmaaden
DK516182A (da) Fremgangsmaade til fremstilling af 3-hydroxy-ml-236b derivater, betegnet m-4 og m-4'
DK512286D0 (da) Fremgangsmaade til fremstilling af peptider og middel til brug ved fremgangsmaaden
DK160795C (da) System til hjemmefremstilling af cigaretter, samt fremgangsmaade og indretning til fremstilling af cigaretter ved anvendelse af systemet
DK118685A (da) Bundkonstruktion til kogekar og fremgangsmaade og apparat til fremstilling af samme
DK0544687T3 (da) Høreapparat og fremgangsmåde til dets fremstilling
DK32684D0 (da) Fremgangsmade til fremstilling af 26,26,26,27,27,27-hexafluorlalfa,25-dihydroxycholesterol og mellemprodukter til brug herfor
DK436981A (da) Fremgangsmaade til fremstilling af 25-hydroxy26,26,26,27,27,27,-hexafluor-cholecalciferol og mellemprodukter herved
DK172485D0 (da) 23,23-difluor-1,25-dihydroxycholecalciferol og derivater deraf, fremgangsmaade til fremstilling af disse og mellemprodukter til brug herved
DK25580A (da) Fremgangsmaade til fremstilling af 2-substituerede trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1h-pyrido (4,3-b) indoler og mellemprodukter heraf
DK155281C (da) Fremgangsmaade til fremstilling af 1,2-dihydro-6-methyl-2-oxo-5-(pyridinyl)nicotinonitriler
DK195585D0 (da) 4'-deschlorrebeccamycin og fremgangsmaade til fremstilling af samme
DK540984A (da) Fremgangsmaade til fremstilling af 1,2,4-triazolo-(1,5-a)pyrimidin-2-sulfonylchlorider
DK157855C (da) Fremgangsmaade til fremstilling af 2,3-dichlor-5-trichlormethylpyridin
DK408183D0 (da) Fremgangsmade til fremstilling af 2-(5,5-disubstitueret 4-oxo-2-imidazolin-2-yl)-nicotinsyrer og quinolin-3-carboxylsyrer
DK589483D0 (da) Mikrobiel loebe, fremgangsmade til fremstilling deraf og plasmider til anvendelse ved fremgangsmaden
DK467780A (da) Fremgangsmaade til fremstilling af 24,24-difluor25-hydrochlecalciferol og mellemprodukter til brug ved fremgangsmaaden
DK160489C (da) Fremgangsmaade til fremstilling af 2,3-difluorpyridinforbindelser
DK93684D0 (da) Fremgangsmade til adjuvering af oliefri vacciner
DK173584D0 (da) Fremgangsmaade til fremstilling af 1,8-dihydroxy-10-acyl-9-anthroner
DK593284D0 (da) Fremgangsmaade til fremstilling af nylon-blokcopolymere og middel tilbrug ved fremgangsmaaden
DK406484A (da) 16-flour-16,17-didehydroprostanoider samt fremgangsmaade til og mellemprodukter ved fremstilling heraf
DK565482A (da) Fremgangsmaade til fremstilling af 1,1-alkandiol-dicarboxylsyreestere, og mellemprodukter for disse estere
DK153488C (da) Fremgangsmaade til fremstilling af 5,6,7,7a-tetrahydro-4h-thieno(3,2-c-)-pyridin-2-onderivater
DK274882A (da) Fremgangsmaade til fremstilling af 4alfa,5alfa-epoxy-3,20-dioxopregnen-2alfa,16alfa-dicarbonitril og mellemprodukt herved

Legal Events

Date Code Title Description
ATS Application withdrawn